<乌鸦传媒>Cases of Breast Implant-Associated Lymphoma Continue to Accumulate More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
<乌鸦传媒>'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
<乌鸦传媒>Antibody-Drug Conjugates Take Breast Cancer Field by Storm Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
<乌鸦传媒>These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
<乌鸦传媒>How to Make Meaningful Moves Toward Health Equity in Cancer Care Addressing the three R's: resources, research, and racism Feb 27, 2023
<乌鸦传媒>Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patients Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
<乌鸦传媒>FDA Greenlights First Drug for ESR1-Mutated Breast Cancer Elacestrant almost doubled PFS versus standard endocrine therapy in advanced ER+/HER2- disease Jan 30, 2023
<乌鸦传媒>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<乌鸦传媒>Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgery Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
<乌鸦传媒>Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancer Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
<乌鸦传媒>Mixed Results With Hormonal Strategies for Premenopausal Breast Cancer Exemestane reduced recurrence, metastasis versus tamoxifen, but no survival benefit Dec 20, 2022
<乌鸦传媒>Less Is More Wins Again: Avoiding Node Dissection in Early Breast Cancer First comparison of targeted sentinel node assessment shows no difference in recurrence rates Dec 09, 2022
<乌鸦传媒>Adding AKT Inhibitor Doubles PFS in Advanced, HR-Positive Breast Cancer In phase III trial, capivasertib benefited patients with or without AKT pathway alterations Dec 09, 2022
<乌鸦传媒>Oral SERD Tops Fulvestrant for PFS in ER-Positive Breast Cancer Camizestrant also led to meaningful PFS improvements in those with detectable ESR1 mutations Dec 09, 2022
<乌鸦传媒>Continuing CDK4/6 Inhibitor Beyond Progression No Help in Metastatic Breast Cancer Prior therapy, baseline mutations confound results; "intriguing" benefit with PD-L1 inhibitor Dec 09, 2022
<乌鸦传媒>Pausing Endocrine Therapy for Pregnancy Safe in Early Breast Cancer Study suggests no increased risk of cancer recurrence versus historical control Dec 09, 2022
<乌鸦传媒>T-DXd Continues Winning Streak in Metastatic, HER2-Positive Breast Cancer Trastuzumab deruxtecan improves survival in second- and later-line settings Dec 08, 2022
<乌鸦传媒>Neoadjuvant T-DXd Active in HER2-Low Breast Cancer Response rates on the order of 58-68%, with or without endocrine therapy Dec 08, 2022
<乌鸦传媒>Everolimus Fails Again as Adjuvant Therapy for High-Risk Breast Cancer No improvement in the overall analysis but a hint of benefit in premenopausal patients Dec 08, 2022
<乌鸦传媒>Assay Predicts Breast Cancer Patients Who Will Benefit From Ovarian Suppression Low score suggests improved outcomes with ovarian suppression plus adjuvant endocrine therapy Dec 07, 2022
<乌鸦传媒>First-Line CDK4/6 Thumps Chemo in Aggressive, Advanced Breast Cancer Doubling of PFS could be death knell for combination chemotherapy in difficult-to-treat subgroup Dec 07, 2022
<乌鸦传媒>Metastasis 'Doorway' May Lead to Racial Disparities in Breast Cancer Density of cellular complex after neoadjuvant therapy tied to cancer subtypes, may be targetable Dec 07, 2022
<乌鸦传媒>Exercise During Chemo Shows Benefits for Cardiorespiratory Fitness However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
<乌鸦传媒>RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Later But "that's not the intent of radiation therapy," says outside expert Nov 18, 2022
<乌鸦传媒>Oral, Hormone-Free Med Reduces Hot Flashes in Breast Cancer Patients Q-122 was effective, well-tolerated in those on oral adjuvant endocrine therapy Nov 11, 2022
<乌鸦传媒>My Risk Revealed: A Confirmed BRCA2 Mutation My dad's cancer diagnosis offered me invaluable information Oct 30, 2022
<乌鸦传媒>Study Suggests Potential to Skip Surgery for Selected Breast Cancer Patients No recurrences in 2 years after pathologic complete response in TNBC, HER2-positive tumors Oct 26, 2022
<乌鸦传媒>Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
<乌鸦传媒>Nerve-Freezing Technique Staves Off Post-Mastectomy Pain Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
<乌鸦传媒>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancer "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<乌鸦传媒>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggests Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<乌鸦传媒>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer Risk is low but appears to have modifiable components Oct 13, 2022
<乌鸦传媒>Katie Couric's Breast Cancer The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022
<乌鸦传媒>Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancer But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
<乌鸦传媒>Denosumab Halts Bone Loss From Ovarian Suppression, AIs for Breast Cancer Areal BMD increased when given at the start of maximal estradiol depletion therapy Sep 13, 2022
<乌鸦传媒>Targeted Combo Flops as First-Line Treatment in Advanced Breast Cancer No clinical benefit boost with anti-CD73 oleclumab added to durvalumab and chemo Sep 10, 2022
<乌鸦传媒>Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing Sep 09, 2022
<乌鸦传媒>2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancer Tamoxifen protects low-risk premenopausal patients, goserelin helps high-risk patients Aug 31, 2022
<乌鸦传媒>Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes? Swedish study finds reduced DFS in women who used drugs for hot flashes Jun 22, 2022
<乌鸦传媒>Diabetes Threatens Long-Term Survival in Metastatic Breast Cancer 5-year survival rates were not affected, however Jun 13, 2022
